Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Clinical trial NCT02860559 · UNKNOWN
Trial details
- NCT number
- NCT02860559
- Sponsor
- Taiga Biotechnologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2024-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.